stockrowCVS Health Corporation
CVS Healthcare Healthcare Plans
CVS Health Corporation’s revenue for fiscal 2025 (year ended December 2025) was $402.1 billion, up 7.85% from fiscal 2024.
- Revenue
- +5.37%
- EPS
- +154.1%
- Free cash flow
- +3,886.7%
- Total debt
- −7.83%
Quarter to September 2026, against a year earlier
Follow CVS
Alert me
CVS Health Corporation (CVS) Return on equity
CVS Health Corporation's return on equity over the twelve months to 30 September 2026 was 14.4%, up 12.0 percentage points from fiscal 2025 (2.34%). Over the past ten years it has ranged from −1.23% (fiscal 2018) to 17.8% (fiscal 2017); the current reading is higher than 18% of that period. That is above the Healthcare Plans industry median of 13.6% and above the Healthcare sector median of −26.0%.
Return on equity, annual
Embed this chart
Annual newest first
| Period | Return on equity | Change (points) |
|---|---|---|
| FY2025 | 2.34% | (3.72) |
| FY2024 | 6.06% | (5.18) |
| FY2023 | 11.2% | 5.38 |
| FY2022 | 5.86% | (5.17) |
| FY2021 | 11.0% | 0.30 |
| FY2020 | 10.7% | (0.08) |
| FY2019 | 10.8% | 12.04 |
| FY2018 | −1.23% | (19.00) |
| FY2017 | 17.8% | 3.41 |
| FY2016 | 14.4% | 0.43 |
Against its own ten years
Return on equity against peers
| Company | Return on equity |
|---|---|
| OSCR Oscar Health, Inc. compare | 52.6% |
| PGNY Progyny, Inc. compare | 18.7% |
| UNH UnitedHealth Group Incorporated compare | 15.4% |
| CVS CVS Health Corporation | 14.4% |
| CI Cigna Group compare | 14.0% |
| ELV Elevance Health, Inc. compare | 11.6% |
| CNC Centene Corporation compare | 6.74% |
| HUM Humana Inc. compare | 6.65% |
| MOH Molina Healthcare, Inc compare | −1.15% |
| Healthcare Plans industry median | 13.6% |
| Healthcare sector median | −26.0% |
| Market median | 1.01% |
What Return on equity is
ROE shows how much profit a company earns for its shareholders on the equity they have in the business.
Annual: Net Income Allotted to Shareholders ÷ Average Common Equity; TTM: Net Income Allotted to Shareholders ÷ Average Common Equity (latest quarter)
More on CVS
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement